MedTrace Logo

Study Evaluating A Novel Ibuprofen Formulation In Episodic Tension-Type Headache

NCT01077973 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2012-08-20

Study results available
· View outcomes & findings →

Summary

This study will compare the ability of a single-dose of a novel ibuprofen formulation to relieve pain compared to placebo and standard ibuprofen in the treatment of episodic tension-type headache.

Conditions

Interventions

DRUG

Novel Ibuprofen

Single-dose of novel ibuprofen (equal to 400 mg ibuprofen) plus placebo

DRUG

Standard Ibuprofen

Single-dose of standard ibuprofen (400mg) plus placebo

DRUG

Placebo

Single-dose of placebo

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-10-31
Completion
2010-10-31

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01077973 on ClinicalTrials.gov